Liver Tumors 2012
DOI: 10.5772/32890
|View full text |Cite
|
Sign up to set email alerts
|

Treatment Strategy for Recurrent Hepatocellular Carcinoma

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

2015
2015
2021
2021

Publication Types

Select...
2

Relationship

0
2

Authors

Journals

citations
Cited by 2 publications
(1 citation statement)
references
References 85 publications
(77 reference statements)
0
1
0
Order By: Relevance
“…Although various methods of tumour ablation have been developed, most studies have utilised RFA to treat recurrent HCC. Experience from ablation in primary HCC shows that RFA and MWA are able to treat tumours up to 6 or 7 cm in diameter and require fewer treatment sessions than PEI [38]. To date, no studies have sought to directly compare RFA, MWA and PEI for the treatment of recurrent disease.…”
Section: Discussionmentioning
confidence: 99%
“…Although various methods of tumour ablation have been developed, most studies have utilised RFA to treat recurrent HCC. Experience from ablation in primary HCC shows that RFA and MWA are able to treat tumours up to 6 or 7 cm in diameter and require fewer treatment sessions than PEI [38]. To date, no studies have sought to directly compare RFA, MWA and PEI for the treatment of recurrent disease.…”
Section: Discussionmentioning
confidence: 99%